MedTrace Logo

Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study

NCT06464341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 583

Last updated 2025-01-20

No results posted yet for this study

Summary

The purposes of this multicenter retrospective cohort study are to determine the residual nodal burden in patients with isolated tumor cells detected in the SLN or the clipped node after NAC and to determine oncologic outcomes in this group of patients after ALND or nodal RT or observation.

Conditions

Interventions

OTHER

Observational study no intervention

Observational study no intervention

Sponsors & Collaborators

Principal Investigators

  • Walter P. Weber, MD · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-04
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • United States
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Germany
  • Greece
  • Israel
  • Italy
  • Netherlands
  • Poland
  • Slovenia
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06464341 on ClinicalTrials.gov